Gout
Conditions
Interventions
rasburicase 0,15mg/kg, once a week during 3 months. Premedication: clemastine and methylprednisolon.
Sponsors
Sanofi, Reade foundation
Eligibility
Inclusion criteria
Inclusion criteria: Adults with severe tophaceous gout
Exclusion criteria
Exclusion criteria: non-compensated congestive heart failure, prior treatment with a recombinant uricase, pregnancy, known allergy for rasburicase or added substances as described in the SmPC of Fasurtec. Known glucose-6-phosphate dehydrogenase deficiency or other cellular metabolic disorder causing hemolytic anemia. Recipient of an investigational drug within 4 weeks prior to study drug administration.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| serum uric acid (mmol/l) | — |
Secondary
| Measure | Time frame |
|---|---|
| patient related outcomes, safety measures. | — |
Contacts
Public ContactDaisy Vedder
Reade
Outcome results
None listed